David Liu is CEO of Sonde Health, a company using vocal biomarkers to assess patient health, wellness, and fitness. The company is white labeling its solution for app developers with initial products for respiratory and mental health problems.
In the interview, Liu discusses the product, technology, and key markets serving as the first adopters. These include healthcare providers and payers along with one industry I wasn’t expecting.
Liu has been CEO of Sonde Health since 2019. He previously was the chief operating officer at Quartet Health and education technology company Knewton and was a senior vice president at AOL. He earned an engineering degree from Purdue and an MBA from Columbia.
Follow @bretkinsella Follow @voicebotai
Healthcare Voice Assistant Data Deep Dive – Voicebot Podcast Ep 242
Voice Assistant Use in Healthcare Nearly Tripled Over Two Years and Demand Still Outstrips Supply – New Report
Chris Maeda CTO of Botco on AI for eCommerce, Marketing, and Healthcare – Voicebot Podcast Ep 249
Bret is founder, CEO, and research director of Voicebot.ai. He was named analyst and journalist of the year in 2019, 2020, and 2021 and is widely cited in media and academic research as an authority on voice assistants and AI. He is also the host of the Voicebot Podcast and editor of the Voice Insider newsletter.
‘This too shall pass away’ this famous Persian adage seems to be defeating us again and again in the case of COVID-19. Despite every effort